Hsbc Holdings PLC Grows Stake in The Cooper Companies, Inc. $COO

Hsbc Holdings PLC raised its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 12.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 403,103 shares of the medical device company’s stock after purchasing an additional 43,812 shares during the period. Hsbc Holdings PLC’s holdings in Cooper Companies were worth $28,755,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Cooper Companies by 48.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after acquiring an additional 7,363 shares in the last quarter. First Trust Advisors LP grew its holdings in Cooper Companies by 115.8% during the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after acquiring an additional 73,165 shares in the last quarter. Cresset Asset Management LLC purchased a new position in Cooper Companies during the 2nd quarter valued at about $291,000. Cerity Partners LLC increased its position in Cooper Companies by 4.4% during the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock valued at $1,272,000 after purchasing an additional 757 shares during the period. Finally, Daiwa Securities Group Inc. increased its position in Cooper Companies by 2.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after purchasing an additional 973 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on COO. Stifel Nicolaus lowered their price target on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Citigroup reissued a “neutral” rating and set a $76.00 price objective (up from $69.00) on shares of Cooper Companies in a report on Wednesday, July 8th. Mizuho set a $85.00 price objective on shares of Cooper Companies and gave the stock an “outperform” rating in a research note on Thursday, June 4th. Weiss Ratings lowered Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, Cooper Companies has an average rating of “Hold” and an average price target of $81.85.

Cooper Companies Stock Down 0.8%

NASDAQ:COO opened at $71.01 on Wednesday. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The stock has a market capitalization of $13.85 billion, a P/E ratio of 60.18, a P/E/G ratio of 1.87 and a beta of 0.84. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The company’s 50-day simple moving average is $66.71 and its 200-day simple moving average is $72.36.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.